# A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients

> **NCT03402087** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 30 (actual)

## Conditions studied

- Lupus
- Psoriatic Arthritis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Leucovorin
- **DRUG:** BMS-986165

## Key facts

- **NCT ID:** NCT03402087
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-08
- **Primary completion:** 2018-03-20
- **Final completion:** 2018-03-25
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03402087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03402087, "A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03402087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*